{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T16:07:01Z","timestamp":1794499621493,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Duchenne muscular dystrophy (DMD), an X-linked recessive condition is maternally inherited in two-thirds of affected boys. It is important to establish carrier status of female relatives to restore reproductive confidence for non-carriers and facilitate reproductive options and cardiac surveillance for carriers. This study investigates disease incidence within an Australian model of cascade screening and evolving genetic diagnostic technologies. A retrospective population-based cohort study of all genetically and\/or histopathologically confirmed males with DMD, born in New South Wales and the Australian Capital Territory was undertaken from 2002\u20132012. Cases were identified using state-wide molecular laboratory and clinical databases. The annual disease incidence and \u201ctheoretically\u201d preventable cases were extrapolated over the study period. Proband genotype\/phenotype, pedigree analysis, carrier-risk and extent of cascade screening were also determined. The cumulative incidence of disease was 19.7 per 100,000 male live births and 1 in 5076 live born males were diagnosed with DMD. Differences in disease incidence were not statistically different when compared between 2002\u20132007 and 2008\u20132012 (incidence rate ratio\u2009=\u20091.13, 95% CI 0.76\u20131.69, <jats:italic>p<\/jats:italic>\u2009=\u20090.52). The incidence rate ratio of theoretically preventable cases did not significantly change between 2002\u20132007 and 2008\u20132012 (incidence rate ratio\u2009=\u20092.07, 95% CI 0.58\u20139.21, <jats:italic>p<\/jats:italic>\u2009=\u20090.23). Current diagnostic and cascade screening models have limitations in their impact on disease incidence, due to a spectrum of logistical, patient and condition related factors. Innovative approaches to reduce DMD incidence may be better achieved by preconception or early pregnancy carrier screening, prenatal exome sequencing and newborn screening.<\/jats:p>","DOI":"10.1038\/s41431-022-01138-2","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T02:02:42Z","timestamp":1656295362000},"page":"1398-1404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Incidence of Duchenne muscular dystrophy in the modern era; an Australian study"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4176-4010","authenticated-orcid":false,"given":"Didu","family":"Kariyawasam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"D\u2019Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mowat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqui","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"1138_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-u","volume":"1","author":"AE Emery","year":"1991","unstructured":"Emery AE. Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord. 1991;1:19\u201329. https:\/\/doi.org\/10.1016\/0960-8966(91)90039-u.","journal-title":"Neuromuscul Disord"},{"key":"1138_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3978\/j.issn.2305-5839.2015.10.45","volume":"3","author":"AE Stark","year":"2015","unstructured":"Stark AE. Determinants of the incidence of Duchenne muscular dystrophy. Ann Transl Med. 2015;3:287 https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.10.45.","journal-title":"Ann Transl Med"},{"key":"1138_CR3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/jpc.12868","volume":"51","author":"EM Yiu","year":"2015","unstructured":"Yiu EM, Kornberg AJ. Duchenne muscular dystrophy. J Paediatr Child Health. 2015;51:759\u201364. https:\/\/doi.org\/10.1111\/jpc.12868.","journal-title":"J Paediatr Child Health"},{"key":"1138_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3233\/JND-170280","volume":"4","author":"Z Koeks","year":"2017","unstructured":"Koeks Z, Bladen CL, Salgado D, van Zwet E, Pogoryelova O, McMacken G, et al. Clinical outcomes in Duchenne Muscular Dystrophy: a Study of 5345 patients from the TREAT-NMD DMD Global Database. J Neuromuscul Dis. 2017;4:293\u2013306. https:\/\/doi.org\/10.3233\/JND-170280.","journal-title":"J Neuromuscul Dis"},{"key":"1138_CR5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10654-020-00613-8","volume":"35","author":"E Landfeldt","year":"2020","unstructured":"Landfeldt E, Thompson R, Sejersen T, McMillan HJ, Kirschner J, Lochm\u00fcller H. Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis. Eur J Epidemiol. 2020;35:643\u201353. https:\/\/doi.org\/10.1007\/s10654-020-00613-8.","journal-title":"Eur J Epidemiol"},{"key":"1138_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","volume":"36","author":"CL Bladen","year":"2015","unstructured":"Bladen CL, Salgado D, Monges S, Foncuberta ME, Kekou K, Kosma K, et al. The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations. Hum Mutat. 2015;36:395\u2013402. https:\/\/doi.org\/10.1002\/humu.22758.","journal-title":"Hum Mutat"},{"key":"1138_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF02717892","volume":"83","author":"JBS Haldane","year":"2004","unstructured":"Haldane JBS. The rate of spontaneous mutation of a human gene. J Genet. 2004;83:235\u201344.","journal-title":"J Genet"},{"key":"1138_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0960-8966(02)00213-4","volume":"13","author":"K Bushby","year":"2003","unstructured":"Bushby K, Muntoni F, Bourke J. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord. 2003;13:166\u201372.","journal-title":"Neuromuscul Disord"},{"key":"1138_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/jmg.27.11.683","volume":"27","author":"T Grimm","year":"1990","unstructured":"Grimm T, M\u00fcller B, M\u00fcller C, Janka M. Theoretical considerations on germline mosaicism in Duchenne muscular dystrophy. J Med Genet. 1990;27:683\u201387.","journal-title":"J Med Genet"},{"key":"1138_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/jmg.26.9.553","volume":"26","author":"E Bakker","year":"1989","unstructured":"Bakker E, Veenema H, Den Dunnen J, Van Broeckhoven C, Grootscholten P, Bonten E. et al. Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations. J Med Genet. 1989;26:553\u201359.","journal-title":"J Med Genet"},{"key":"1138_CR11","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH, Kunkel LM. Dystrophin: The protein product of the duchenne muscular dystrophy locus. Cell. 1987;51:919\u201328. https:\/\/doi.org\/10.1016\/0092-8674(87)90579-4.","journal-title":"Cell"},{"key":"1138_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0074-7696(04)40001-1","volume":"240","author":"V Voisin","year":"2004","unstructured":"Voisin V, de la Porte S. Therapeutic strategies for Duchenne and Becker dystrophies. Int Rev Cytol. 2004;240:1\u201330. https:\/\/doi.org\/10.1016\/s0074-7696(04)40001-1.","journal-title":"Int Rev Cytol"},{"key":"1138_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/jhg.2016.7","volume":"61","author":"M Okubo","year":"2016","unstructured":"Okubo M, Minami N, Goto K, Goto Y, Noguchi S, Mitsuhashi S, et al. Genetic diagnosis of Duchenne\/Becker muscular dystrophy using next-generation sequencing: validation analysis of DMD mutations. J Hum Genet. 2016;61:483\u20139. https:\/\/doi.org\/10.1038\/jhg.2016.7.","journal-title":"J Hum Genet"},{"key":"1138_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/pd.1970040406","volume":"4","author":"R Edwards","year":"1984","unstructured":"Edwards R, Watts D, Watts R, Rodeck C. Creatine kinase estimation in pure fetal blood samples for the prenatal diagnosis of Duchenne muscular dystrophy. J Prenat diagnosis. 1984;4:267\u201377.","journal-title":"J Prenat diagnosis"},{"key":"1138_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.0004-8666.2002.00085.x","volume":"42","author":"D Ladwig","year":"2002","unstructured":"Ladwig D, Mowat D, Tobias V, Taylor PJ, Buckley MF, McNally G, et al. obstetrics NZjo, gynaecology. In utero fetal muscle biopsy in the diagnosis of Duchenne muscular dystrophy. Aust N. Z J Obstet Gynaecol. 2002;42:85\u201388.","journal-title":"Aust N. Z J Obstet Gynaecol"},{"key":"1138_CR16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jmg.2006.047464","volume":"44","author":"PJ Taylor","year":"2007","unstructured":"Taylor PJ, Maroulis S, Mullan GL, Pedersen RL, Baumli A, Elakis G, et al. Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy. J Med Genet. 2007;44:368\u201372. https:\/\/doi.org\/10.1136\/jmg.2006.047464.","journal-title":"J Med Genet"},{"key":"1138_CR17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1377\/hlthaff.2017.1630","volume":"37","author":"MC Roberts","year":"2018","unstructured":"Roberts MC, Dotson WD, DeVore CS, Bednar EM, Bowen DJ, Ganiats TG, et al. Delivery Of cascade screening for hereditary conditions: a scoping review of the literature. Health Aff. 2018;37:801\u201308. https:\/\/doi.org\/10.1377\/hlthaff.2017.1630.","journal-title":"Health Aff"},{"key":"1138_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1399-0004.2012.01876.x","volume":"83","author":"R McGowan","year":"2013","unstructured":"McGowan R, Challoner BR, Ross S, Holloway S, Joss S, Wilcox D, et al. Results of Duchenne muscular dystrophy family screening in practice: leaks rather than cascades? Journa Clin Genet. 2013;83:187\u201390. https:\/\/doi.org\/10.1111\/j.1399-0004.2012.01876.x.","journal-title":"Journa Clin Genet"},{"key":"1138_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13023-017-0631-3","volume":"12","author":"S Ryder","year":"2017","unstructured":"Ryder S, Leadley RM, Armstrong N, Westwood M, de Kock S, Butt T, et al. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet J rare Dis. 2017;12:79\u201379. https:\/\/doi.org\/10.1186\/s13023-017-0631-3.","journal-title":"Orphanet J rare Dis"},{"key":"1138_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1399-0004.2010.01579.x","volume":"79","author":"AT Helderman-van den Enden","year":"2011","unstructured":"Helderman-van den Enden AT, van den Bergen JC, Breuning MH, Verschuuren JJ, Tibben A, Bakker E, et al. Duchenne\/Becker muscular dystrophy in the family: have potential carriers been tested at a molecular level? Clin Genet. 2011;79:236\u201342. https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01579.x.","journal-title":"Clin Genet"},{"key":"1138_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/0009922809347777","volume":"49","author":"J Dooley","year":"2010","unstructured":"Dooley J, Gordon KE, Dodds L, MacSween J. Duchenne muscular dystrophy: a 30-year population-based incidence study. Clin Pediatr. 2010;49:177\u201379.","journal-title":"Clin Pediatr"},{"key":"1138_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/jmg.17.4.245","volume":"17","author":"J Cowan","year":"1980","unstructured":"Cowan J, Macdessi J, Stark A, Morgan G. Incidence of Duchenne muscular dystrophy in New South Wales and Australian Capital Territory. J Med Genet. 1980;17:245\u20139. https:\/\/doi.org\/10.1136\/jmg.17.4.245.","journal-title":"J Med Genet"},{"key":"1138_CR23","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.nmd.2006.05.244","volume":"16","author":"F Eyskens","year":"2006","unstructured":"Eyskens F, Philips E. G.P.10 10 Newborn screening for Duchenne muscular dystrophy. The experience in the province of Antwerp. Neuromusc Disord. 2006;16:721","journal-title":"Neuromusc Disord"},{"key":"1138_CR24","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","volume":"21","author":"SJ Moat","year":"2013","unstructured":"Moat SJ, Bradley DM, Salmon R, Clarke A, Hartley L. Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK). Eur J Hum Genet. 2013;21:1049\u201353.","journal-title":"Eur J Hum Genet"},{"key":"1138_CR25","first-page":"GNP","volume":"50","author":"A Pechmann","year":"2019","unstructured":"Pechmann A, K\u00f6nig K, Thiele S, Walter MC, Schorling D, Tassoni A, et al. De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in germany. J Neuropediatrics. 2019;50:GNP\u2013PO60.","journal-title":"J Neuropediatrics"},{"key":"1138_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-020-01430-8","volume":"15","author":"S Crisafulli","year":"2020","unstructured":"Crisafulli S, Sultana J, Fontana A, Salvo F, Messina S, Trifir\u00f2 G. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet J rare Dis. 2020;15:1\u201320.","journal-title":"Orphanet J rare Dis"},{"key":"1138_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018;17:347\u201361. https:\/\/doi.org\/10.1016\/S1474-4422(18)30025-5.","journal-title":"Lancet Neurol"},{"key":"1138_CR28","unstructured":"Le Anh Tuan-Pham TH, Tran DQT, Nguyen Thi Minh NLH, Nguyen Viet Tien VTT, The Hung Bui VKT. AB163. Microsatellite markers for preimplantation genetic diagnosis in Vietnamese DMD and hemophilia: a female carriers. Ann Transl Med. 2015;3."},{"key":"1138_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1651-2227.1989.tb10894.x","volume":"78","author":"S Tangsrud","year":"1989","unstructured":"Tangsrud S, Halvorsen SJAP. Child neuromuscular disease in southern Norway: The prevalence and incidence of Duchenne muscular dystrophy. Acta Paediatr. 1989;78:100\u201303.","journal-title":"Acta Paediatr"},{"key":"1138_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41431-020-0685-x","volume":"29","author":"EP Kirk","year":"2021","unstructured":"Kirk EP, Ong R, Boggs K, Hardy T, Righetti S, Kamien B, et al. Gene selection for the Australian Reproductive Genetic Carrier Screening Project (\u201cMackenzie\u2019s Mission\u201d). Eur J Hum Genet. 2021;29:79\u201387. https:\/\/doi.org\/10.1038\/s41431-020-0685-x.","journal-title":"Eur J Hum Genet"},{"key":"1138_CR31","unstructured":"P T. Molecular Genetic Analysis of a New South Wales Muscular Dystrophy Cohort University of New South Wales 2008:134 \u201344"},{"key":"1138_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF00275183","volume":"66","author":"H Moser","year":"1984","unstructured":"Moser H. Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention. Hum Genet. 1984;66:17\u201340.","journal-title":"Hum Genet"},{"key":"1138_CR33","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","volume":"24","author":"JK Mah","year":"2014","unstructured":"Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. J Neuromuscul Disord. 2014;24:482\u201391.","journal-title":"J Neuromuscul Disord"},{"key":"1138_CR34","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0960-8966(03)00162-7","volume":"13","author":"J Jeppesen","year":"2003","unstructured":"Jeppesen J, Green A, Steffensen B, Rahbek JJND. The Duchenne muscular dystrophy population in Denmark, 1977\u20132001: prevalence, incidence and survival in relation to the introduction of ventilator use. Neuromuscul Disord. 2003;13:804\u201312.","journal-title":"Neuromuscul Disord"},{"key":"1138_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/GIM.0b013e31818fa2ff","volume":"11","author":"AO Berg","year":"2009","unstructured":"Berg AO, Armstrong K, Botkin J, Calonge N, Haddow J, Hayes M, et al. Richards CSJGiM. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009;11:35\u201341.","journal-title":"Genet Med"},{"key":"1138_CR36","unstructured":"Brown SE, Bobrow M Dystrophin: gene, protein and cell biology: Cambridge University Press, 1997."},{"key":"1138_CR37","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/bf00210802","volume":"84","author":"G Barbujani","year":"1990","unstructured":"Barbujani G, Russo A, Danieli GA, Spiegler AW, Borkowska J, Petrusewicz IH. Segregation analysis of 1885 DMD families: significant departure from the expected proportion of sporadic cases. Hum Genet. 1990;84:522\u20136. https:\/\/doi.org\/10.1007\/bf00210802.","journal-title":"Hum Genet"},{"key":"1138_CR38","first-page":"179","volume":"31","author":"T Grimm","year":"2012","unstructured":"Grimm T, Kress W, Meng G, M\u00fcller CR. Risk assessment and genetic counseling in families with Duchenne muscular dystrophy. Acta Myol. 2012;31:179","journal-title":"Acta Myol"},{"key":"1138_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12519-019-00242-6","volume":"15","author":"Q Ke","year":"2019","unstructured":"Ke Q, Zhao ZY, Mendell JR, Baker M, Wiley V, Kwon JM, et al. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy. World J Pediatr. 2019;15:219\u201325. https:\/\/doi.org\/10.1007\/s12519-019-00242-6.","journal-title":"World J Pediatr"},{"key":"1138_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ejhg.2012.101","volume":"21","author":"AT Helderman-van Den Enden","year":"2013","unstructured":"Helderman-van Den Enden AT, Madan K, Breuning MH, Van Der Hout AH, Bakker E, de Die-Smulders CE. et al. An urgent need for a change in policy revealed by a study on prenatal testing for Duchenne muscular dystrophy. Eur J Hum Genet. 2013;21:21\u201326.","journal-title":"Eur J Hum Genet"},{"key":"1138_CR41","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.healthpol.2007.02.007","volume":"83","author":"R Achterbergh","year":"2007","unstructured":"Achterbergh R, Lakeman P, Stemerding D, Moors EH, Cornel MC. Implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies: a sociotechnical analysis. Health Policy. 2007;83:277\u201386.","journal-title":"Health Policy"},{"key":"1138_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/pd.5611","volume":"40","author":"MB Delatycki","year":"2020","unstructured":"Delatycki MB, Alkuraya F, Archibald A, Castellani C, Cornel M, Grody WW, et al. International perspectives on the implementation of reproductive carrier screening. Prenat Diagnosis. 2020;40:301\u201310. https:\/\/doi.org\/10.1002\/pd.5611.","journal-title":"Prenat Diagnosis"},{"key":"1138_CR43","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/pd.5352","volume":"38","author":"A Poulton","year":"2018","unstructured":"Poulton A, Lewis S, Hui L, Halliday JL. Prenatal and preimplantation genetic diagnosis for single gene disorders: A population\u2010based study from 1977 to 2016. Prenat Diagnosis. 2018;38:904\u201310.","journal-title":"Prenat Diagnosis"},{"key":"1138_CR44","unstructured":"New help for Australians on the IVF journey. Secondary New help for Australians on the IVF journey 2021. https:\/\/www.health.gov.au\/ministers\/the-hon-greg-hunt-mp\/media\/new-help-for-australians-on-the-ivf-journey."},{"key":"1138_CR45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/aog.0000000000004229","volume":"137","author":"J Silver","year":"2021","unstructured":"Silver J, Norton ME. Expanded carrier screening and the complexity of implementation. Obstet Gynaecol. 2021;137:345\u201350. https:\/\/doi.org\/10.1097\/aog.0000000000004229.","journal-title":"Obstet Gynaecol"},{"key":"1138_CR46","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/ejhg.2015.271","volume":"24","author":"L Henneman","year":"2016","unstructured":"Henneman L, Borry P, Chokoshvili D, Cornel MC, van El CG, Forzano F, et al. Responsible implementation of expanded carrier screening. Eur J Hum Genet. 2016;24:e1\u2013e12. https:\/\/doi.org\/10.1038\/ejhg.2015.271.","journal-title":"Eur J Hum Genet"},{"key":"1138_CR47","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1093\/humrep\/deab087","volume":"36","author":"A Capalbo","year":"2021","unstructured":"Capalbo A, Fabiani M, Caroselli S, Poli M, Girardi L, Patassini C, et al. Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population. Hum Reprod. 2021;36:2050\u201361. https:\/\/doi.org\/10.1093\/humrep\/deab087.","journal-title":"Hum Reprod"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01138-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01138-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01138-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T01:05:22Z","timestamp":1669856722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01138-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1138"],"URL":"https:\/\/doi.org\/10.1038\/s41431-022-01138-2","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"17 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Sydney Children\u2019s Hospital Network and South-Eastern Sydney and Illawarra Area Health Service Human Research Ethics Committee (HREC LNR\/18\/SCHN\/243). A waiver for obtaining consent from children and their families was encompassed within this Ethic approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}